gadelkarim, A., Abdel Raheem, O., Ali Saleem, A. (2023). Outcomes of Sleeve Gastrectomy in Obese Patients: A Retrospective Study. The Egyptian Journal of Hospital Medicine, 90(2), 3053-3061. doi: 10.21608/ejhm.2023.288390
ahmed gadelkarim; Omar Abdel Raheem; Abd-El-Aal Ali Saleem. "Outcomes of Sleeve Gastrectomy in Obese Patients: A Retrospective Study". The Egyptian Journal of Hospital Medicine, 90, 2, 2023, 3053-3061. doi: 10.21608/ejhm.2023.288390
gadelkarim, A., Abdel Raheem, O., Ali Saleem, A. (2023). 'Outcomes of Sleeve Gastrectomy in Obese Patients: A Retrospective Study', The Egyptian Journal of Hospital Medicine, 90(2), pp. 3053-3061. doi: 10.21608/ejhm.2023.288390
gadelkarim, A., Abdel Raheem, O., Ali Saleem, A. Outcomes of Sleeve Gastrectomy in Obese Patients: A Retrospective Study. The Egyptian Journal of Hospital Medicine, 2023; 90(2): 3053-3061. doi: 10.21608/ejhm.2023.288390
Outcomes of Sleeve Gastrectomy in Obese Patients: A Retrospective Study
Department of General Surgery, Faculty of Medicine, Sohag University, Egypt
Abstract
Background: Morbid obesity has become a serious health problem due to its fatal consequences and co-morbidities. It is well-accepted that obesity-related comorbidities may be effectively managed by bariatric surgery. Objective: The aim of the current study is to assess the outcomes of laparoscopic sleeve gastrectomy (LSG) in morbidly obese patients, regarding weight loss, effects on associated comorbidities and post-operative complications. Patients and methods: Our retrospective cohort study was conducted in Sohag University Hospitals. A total of 60 patients who underwent LSG were followed up in the period from January 2017 to May 2018. Participants were patients with BMI ≥40 or BMI = 35–39 with one or more obesity-related co-morbidities. Results: Statistically significant weight reduction occurred at 3, 6, 12, 18 and 24 months after LSG. Regarding the comorbidities, we found that 12 cases had diabetes (4 cases improved and 8 reached remission). The mean HbA1c was within the prediabetic or the controlled diabetic zone for the vast majority of cases, and 6 cases had Hypertension, improvement occurred in 5 cases and one case reached remission. All cases that had dyslipidemia in the study population (5 cases) were completely controlled. Conclusion: LSG can be considered an effective single-stage procedure in morbidly obese patients showing excellent and reliable results for weight loss in obese patients with a significantly low complication rate. This procedure could significantly resolve obesity-related morbidity.